Understanding Lung Cancer Related Risk Factors and Their Impact

LUCIA aims to develop prediction models for the early diagnosis of lung cancer based on the identification of risk factors and deeper cellular knowledge, by recording real-world data; with risk assessment tools, non-invasive devices and omics analysis. These models will enable new clinical pathways and diagnostic workflow to be implemented to ensure early diagnosis and confirmation, including classification of lung cancer subtype.

NCT Number	NCT06473870
Lead Sponsor	Biobizkaia Health Research Institute Collaborators: Technion, Israel Institute of Technology, Centro Nacional de Análisis Genómico, Vicomtech, University of Latvia, Centre Hospitalier Universitaire de Liege, Andaluz Health Service, Nanose Medical Ltd.
Conditions	Lung Cancer Screening
Enrollment	6,160 participants
Start Date	2024-07
Primary Completion	2027-12 (estimated)
Study Completion	2027-12 (estimated)
Updated on ClinicalTrials.gov	2024-06-25